BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
159 results:

  • 1. Group 3 medulloblastoma transcriptional networks collapse under domain specific ep300/CBP inhibition.
    Shendy NAM; Bikowitz M; Sigua LH; Zhang Y; Mercier A; Khashana Y; Nance S; Liu Q; Delahunty IM; Robinson S; Goel V; Rees MG; Ronan MA; Wang T; Kocak M; Roth JA; Wang Y; Freeman BB; Orr BA; Abraham BJ; Roussel MF; Schonbrunn E; Qi J; Durbin AD
    Nat Commun; 2024 Apr; 15(1):3483. PubMed ID: 38664416
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
    Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
    Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
    Yang E; Hong B; Wang Y; Wang Q; Zhao J; Cui X; Wu Y; Yang S; Su D; Liu X; Kang C
    Cancer Lett; 2024 Apr; 588():216812. PubMed ID: 38490327
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
    Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
    Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HDAC8-mediated inhibition of ep300 drives a transcriptional state that increases melanoma brain metastasis.
    Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
    Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.
    Tian Y; Ma J; Wang H; Yi X; Wang H; Zhang H; Guo S; Yang Y; Zhang B; Du J; Shi Q; Gao T; Guo W; Li C
    Cell Mol Life Sci; 2023 Oct; 80(11):315. PubMed ID: 37801083
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Acetylation reprograms MITF target selectivity and residence time.
    Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
    Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300.
    Brown AD; Lynch K; Langelaan DN
    Sci Rep; 2023 Sep; 13(1):16094. PubMed ID: 37752231
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Characterization of molecular mechanisms driving Merkel cell polyomavirus oncogene transcription and tumorigenic potential.
    Yang JF; Liu W; You J
    PLoS Pathog; 2023 Aug; 19(8):e1011598. PubMed ID: 37647312
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. BCOR expression in paediatric pineoblastoma.
    Trubicka J; Łastowska M; Karkucińska-Więckowska A; Niemira M; Ejmont M; Sowińska A; Pronicki M; Matyja E; Grajkowska W
    Folia Neuropathol; 2023; 61(2):121-128. PubMed ID: 37587886
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks.
    Lee K; Yun S; Park J; Lee S; Carcaboso AM; Yi SJ; Kim K
    Biochem Biophys Res Commun; 2023 Oct; 677():6-12. PubMed ID: 37523894
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Smilagenin induces expression and epigenetic remodeling of BDNF in alzheimer's disease.
    Yang S; Fan L; Zhang R; Song C; Shi J; Wang J; Zhang P; Wang H; Zhang Y
    Phytomedicine; 2023 Sep; 118():154956. PubMed ID: 37499345
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor.
    Brown AD; Vergunst KL; Branch M; Blair CM; Dupré DJ; Baillie GS; Langelaan DN
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119520. PubMed ID: 37353163
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.
    Anvari K; Shahabadi M; Welsh JS; Javadinia SA; Zarei E
    Asian Pac J Cancer Prev; 2023 May; 24(5):1507-1511. PubMed ID: 37247269
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan.
    Ogata D; Nishio S; Hatta N; Kaji T; Fujii K; Mikami M; Kiyohara Y; Enomoto T
    Melanoma Res; 2023 Aug; 33(4):300-308. PubMed ID: 37162526
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High-grade neuroepithelial tumor with ep300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
    Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
    Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
    Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
    Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. p300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma.
    Cheng C; He T; Chen K; Cai Y; Gu Y; Pan L; Duan P; Wu Y; Wu Z
    Mol Cell Proteomics; 2023 Mar; 22(3):100504. PubMed ID: 36708875
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PGAM4 silencing inhibited glycolysis and chemoresistance to temozolomide in glioma cells.
    Lu B; Nie XH; Yin R; Ding P; Su ZZ; Qiu S; Qian YF
    Cell Biol Int; 2023 Apr; 47(4):776-786. PubMed ID: 36576012
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ginsenoside Rh2 inhibits CBP/p300-mediated FOXO3a acetylation and epilepsy-induced oxidative damage via the FOXO3a-KEAP1-NRF2 pathway.
    Wu J; Wang S; Zhao W; Li M; Li S
    Eur J Pharmacol; 2023 Feb; 940():175391. PubMed ID: 36400161
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.